Antipsoriatics/dupilumabLack of efficacy and off-label use in unapproved indication: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1961卷 / 1期

关键词：

D O I：

10.1007/s40278-023-41323-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：66 / 66

相关论文

共 50 条

[1] MethylprednisoloneLack of efficacy and off-label use in unapproved indication: case report
[J]. Reactions Weekly, 2024, 2021 (1) : 303 - 303
[2] Dapsone/dupilumabMethaemoglobinaemia and off-label use in unapproved indication: case report
[J]. Reactions Weekly, 2023, 1986 (1) : 161 - 161
[3] Multiple drugsDrug intolerance, lack of efficacy and off-label use (in unapproved indication): case report
[J]. Reactions Weekly, 2023, 1979 (1) : 299 - 299
[4] Abatacept/cyclophosphamideLack of efficacy and off-label use in unapproved indication
[J]. Reactions Weekly, 2024, 2006 (1) : 13 - 13
[5] Azithromycin/hydroxychloroquine/steroidsLack of efficacy and off-label use in an unapproved indication
[J]. Reactions Weekly, 2024, 2014 (1) : 104 - 104
[6] Multiple drugsLack of efficacy and off-label use (in unapproved indication): 4 case reports
[J]. Reactions Weekly, 2023, 1966 (1) : 245 - 245
[7] Baricitinib/dexamethasone/remdesivirLack of efficacy and off-label use in unapproved indication
[J]. Reactions Weekly, 2024, 1999 (1) : 81 - 81
[8] Anti-inflammatoriesLack of efficacy, off-label use in unapproved indication and drug ineffective for unapproved indication: 5 case reports
[J]. Reactions Weekly, 2023, 1960 (1) : 36 - 36
[9] Multiple drugsPolyneuropathy, lack of efficacy and off label use for unapproved indication: case report
[J]. Reactions Weekly, 2021, 1862 (1) : 343 - 343
[10] Azacitidine/VenetoclaxLack of efficacy and off-label therapy in unapproved indication
[J]. Reactions Weekly, 2023, 1986 (1) : 83 - 83

← 1 2 3 4 5 →